GSK-3484862 free base · Synonyms: GSK 3484862 · GSK3484862
GSK-3484862 is a non-covalent inhibitor.
For research use only. Not for human or veterinary use.
Research area
Cancer
Purity >98%
Stock Inquire
GSK-3484862 structure
CAS No.: 2170136-65-7
Pack sizes & pricing
| Size | Price | SKU | Stock | |
|---|---|---|---|---|
| 100 mg | USD 550.00 | BP-01346-100mg | In stock | Get quote |
| 250 mg | USD 900.00 | BP-01346-250mg | In stock | Get quote |
| 500 mg | USD 1,250.00 | BP-01346-500mg | Inquire | Get quote |
| 1 g | USD 1,850.00 | BP-01346-1g | In stock | Get quote |
| 5 g | Inquire | BP-01346-5g | In stock | Inquire |
| 10 g | Inquire | BP-01346-10g | In stock | Inquire |
Description
GSK-3484862 is a non-covalent inhibitor for DNA methyltransferase (Dnmt1). GSK-3484862 induces DNA hypomethylation to against cancer. GSK-3484862 mediates dramatic demethylation in murine embryonic stem cells with minimal non-specific toxicity.
Biological activity
GSK-3484862 is a non-covalent inhibitor for Dnmt1. GSK-3484862 induces DNA hypomethylation to against cancer. GSK-3484862 mediates global demethylation in murine embryonic stem cells.
Identifiers
- SMILES
-
O=C(N)[C@H](SC1=NC(N(C)C)=C(C#N)C(CC)=C1C#N)C2=CC=CC=C2 - InChIKey
-
KIEQQZZDWUNUQK-MRXNPFEDSA-N
Specifications
- MW (average)
- 365.4520
- Formula
- C19H19N5OS
- CAS No.
- 2170136-65-7
- Physical state
- Solid
- Color
- light yellow to yellow
- Shipping
- Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
- Storage
- Powder 4℃ 2 years; In solvent -20℃ 1 month;
Solubility
soluble in DMSO
- In vitro
- DMSO : 20 mg/mL
Documents
References
[1]. Azevedo Portilho N, et al. The DNMT1 inhibitor GSK-3484862 mediates global demethylation in murine embryonic stem cells. Epigenetics Chromatin. 2021;14(1):56. Published 2021 Dec 15.
[2]. Liu Y, et al. DNMT1-targeting remodeling global DNA hypomethylation for enhanced tumor suppression and circumvented toxicity in oral squamous cell carcinoma. Mol Cancer. 2024;23(1):104. Published 2024 May 16.
[3]. Zhuang X, et al. Aging limits stemness and tumorigenesis in the lung by reprogramming iron homeostasis[J]. BioRxiv, 2024: 2024.06. 23.600305.
[4]. Chen Q, et al. GSK-3484862, a DNMT1 degrader, promotes DNMT3B expression in lung cancer cells. NAR Cancer. 2025;7(2):zcaf018. Published 2025 May 27.
Same target
Search DNA MethyltransferaseSame research area
Search Cancer- BP-00006 SLF Exclusive free base · >98%
- BP-00008 NSC-339004 free base · >98%
- BP-00019 SLF-amido-C2-COOH free base · >98%
- BP-00022 Inolitazone free base · >98%
- BP-00030 EML4-ALK kinase inhibitor 1 free base · >98%
- BP-00037 SB 328437 free base · >98%
- BP-00044 Aloc-D-Ala-Phe-Lys(Aloc)-PAB-PNP free base · >98%
- BP-00063 PT-179 free base · >98%